This study by Vasak et al. (AJOG, 2016) sought to determine if there is a higher rate of mortality during the perinatal period among preterm births in singletons versus twin pregnancies.
Cohort study from the nationwide Netherlands Perinatal Registry
1,502,120 singletons and 51,658 twin pregnancies delivered after 28 weeks’ gestation were surveyed. In twin pregnancies the overall perinatal mortality rate was increased, as expected (6.6/1000 vs 4.1/1000) when compared to singleton pregnancies. However, when only the preterm period was analyzed, the risk of perinatal mortality in singletons was higher than in twins (34.5/1000 vs 10.4/1000). The authors propose a hypothesis that this finding of superior outcomes in the preterm period among twins may reflect additional monitoring and that perhaps closer surveillance could benefit singletons as well.
Please log in to ObGFirst to access the 2T US Atlas
OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Jointly provided by
